Your browser doesn't support javascript.
loading
Diagnostic strategy for females suspected of Fabry disease.
Balendran, Sukirthini; Oliva, Petra; Sansen, Stefaan; Mechtler, Thomas P; Streubel, Berthold; Cobos, Paulina N; Lukacs, Zoltan; Kasper, David C.
Afiliación
  • Balendran S; Department of Pathology, The Medical University of Vienna, Vienna, Austria.
  • Oliva P; ARCHIMED Life Science GmbH, Vienna, Austria.
  • Sansen S; Sanofi Genzyme, Amsterdam, Netherlands.
  • Mechtler TP; ARCHIMED Life Science GmbH, Vienna, Austria.
  • Streubel B; Department of Pathology, The Medical University of Vienna, Vienna, Austria.
  • Cobos PN; Newborn Screening and Metabolic Diagnostics Unit, Hamburg University Medical Center, Hamburg, Germany.
  • Lukacs Z; Newborn Screening and Metabolic Diagnostics Unit, Hamburg University Medical Center, Hamburg, Germany.
  • Kasper DC; ARCHIMED Life Science GmbH, Vienna, Austria.
Clin Genet ; 97(4): 655-660, 2020 04.
Article en En | MEDLINE | ID: mdl-31860127
ABSTRACT
A total of 11 948 females suspicious of Fabry disease were tested by a combined biochemical and genetic approach. The enzyme activity, together with the concentration of lyso-GL-3 (lyso-Gb3) biomarker in dried blood spots (DBS), substantially improved the diagnostic detection of Fabry disease in females compared to the enzyme activity alone. Abnormal values for both were highly suspicious of Fabry disease (97% positive predictive value [PPV], similar to PPV in males). In cases with one abnormal biochemical value, elevated lyso-GL-3 is a far more important indicator than low enzyme activity (39% PPV vs 6% PPV). Cases with clearly negative results for both biochemical parameters are unlikely to have Fabry disease, even in clinically highly suspicious cases.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esfingolípidos / Glucolípidos / Biomarcadores / Enfermedad de Fabry Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Clin Genet Año: 2020 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esfingolípidos / Glucolípidos / Biomarcadores / Enfermedad de Fabry Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Clin Genet Año: 2020 Tipo del documento: Article País de afiliación: Austria